In vitro synthesis of recombinant heparan sulfate
In vitro synthesis of recombinant heparan sulfate
批准号:
7867419
负责人:
JIAN LIU
金额:
$4.6万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-13 至 2013-01-31
关键词:
AbbreviationsAdverse effectsAnticoagulantsAntithrombinsAntiviral AgentsBindingBiologicalBiological ProcessBlood coagulationCell Differentiation processCell surfaceDeacetylationDevelopmentDisaccharidesEnzymesExtracellular MatrixGlucosamineHeparan Sulfate BiosynthesisHeparinHeparitin SulfateIduronic AcidIn VitroInflammatory ResponseInorganic SulfatesLeadLibrariesMalignant NeoplasmsMethodsModificationOligosaccharidesPasteurellaPatternPhysiologicalPolysaccharidesPositioning AttributePredispositionReagentRecombinantsSeriesSignal TransductionSpecificityStructureStructure-Activity RelationshipSubstrate SpecificityTaiwanTherapeuticTherapeutic AgentsTransferaseUDP-glucosamineUniversitiesUnspecified or Sulfate Ion Sulfatesbasechemical synthesisdesignepimeraseepimerizationheparosan synthaseimprovedinterestnovelnovel strategiespathogenpublic health relevancesuccesssulfationsulfotransferase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Heparan sulfate (HS) is an essential glycan that is present in large quantities on the cell surface and in the extracellular matrix. HS participates in a variety of physiological and pathophysiological functions, including blood coagulation, inflammatory response and cell differentiation. HS is a highly sulfated polysaccharide. Heparin, a special form of HS, is a commonly used anticoagulant drug. The wide range of biological functions of HS attracts considerable interest in exploiting heparin or heparin-like molecules for the development of anticancer and antiviral drugs. The uniquely distributed sulfation pattern of HS is believed to regulate its functional specificity. However, chemical synthesis of HS, especially those larger than hexasaccharides, is extremely difficult. Using HS biosynthetic enzymes, our labs can produce an array of HS with unique sulfation patterns and functions. Our success has proved the feasibility of conducting enzyme-based synthesis of HS with unique biological activities. The long term aim of this project is to develop a method to synthesize HS with high structural precision. Our hypothesis is that the distribution of N- sulfoglucosamine residues determines the susceptibility of all subsequent modifications during heparan sulfate biosynthesis, including epimerization, 2-O-sulfation, 6-O- sulfation, and 3-O-sulfation. In this proposal, we will synthesize structurally defined oligosaccharides carrying N-sulfoglucosamine residues using glycosyl transferases. We will then determine the substrate specificities of a variety of HS biosynthetic enzymes with the aim of precisely positioning the 6-O-sulfo and 3-O-sulfo groups as well as 2-O- sulfo iduronic acid within oligosaccharides. Finally, we plan to utilize this method to investigate novel anticoagulant HS structures. The success of this project will lead a comprehensive new approach to investigate the structure and function relationship of HS, potentially leading to the development of novel HS-based therapeutic reagents. Public Health Relevance: Heparan sulfate (HS) is a highly sulfated polysaccharide. Heparin, a special form of HS, is a commonly used anticoagulant drug. The wide range of biological functions of HS attracts considerable interest in exploiting heparin or heparin-like molecules for the development of anticancer and antiviral drugs. The uniquely distributed sulfation pattern of HS is believed to regulate its functional specificity. The long term aim of this project is to develop a method to synthesize HS with high structural precision. The success of this project will lead a comprehensive new approach to investigate the structure and function relationship of HS, potentially leading to the development of novel HS-based therapeutic reagents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of heparan sulfate in cathepsin K biology
-
批准号:10665752
-
项目类别:
-
资助金额:$53.96万
-
财政年份:2022
-
负责人:JIAN LIU
-
依托单位:
Development of a New Carbohydrate-based Anticoagulant Drug
-
批准号:9408360
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2017
-
负责人:JIAN LIU
-
依托单位:
Developing Heparan Sulfate Glycan Array
-
批准号:9408339
-
项目类别:
-
资助金额:$14.99万
-
财政年份:2017
-
负责人:JIAN LIU
-
依托单位:
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP
-
批准号:8730574
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
Uncovering the controlling mechanisms in heparan sulfate biosynthesis
-
批准号:8853290
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
Uncovering the controlling mechanisms in heparan sulfate biosynthesis
-
批准号:8576941
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP
-
批准号:9135956
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP
-
批准号:9336703
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP
-
批准号:8703471
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
Uncovering the controlling mechanisms in heparan sulfate biosynthesis
-
批准号:8724523
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
PROBING HEPARIN STRUCTURAL ELEMENTS FOR HIGH RISK OF HEPARIN-INDUCED THROMBOCYTOP
-
批准号:8892053
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:JIAN LIU
-
依托单位:
Structural Specificity of Heparan Sulfate for Herpes Infections
-
批准号:8071314
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2010
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:10218239
-
项目类别:
-
资助金额:$46.37万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:8711536
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:8578129
-
项目类别:
-
资助金额:$39.02万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:7563439
-
项目类别:
-
资助金额:$37.78万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:9069923
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
Glycomics of Heparan Sulfate in Bacterial Pathogenesis
-
批准号:7898843
-
项目类别:
-
资助金额:$19.73万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
Glycomics of Heparan Sulfate in Bacterial Pathogenesis
-
批准号:7739326
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
In vitro synthesis of recombinant heparan sulfate
-
批准号:8212485
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2009
-
负责人:JIAN LIU
-
依托单位:
海外基金